rivastigmine tartrate

FDA Drug Profile

rivastigmine tartrate is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
rivastigmine tartrate
Sponsor
Jubilant Biosys Limited
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
RIVASTIGMINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Rivastigmine tartrate capsule is an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) (1.1) Mild-to-moderate dementia associated with Parkinson’s disease (PD) (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.